Autoimmune diseases and IVIg - Commitment of the LFB

被引：0
|
作者：
Tellier, Z [1 ]
机构：
[1] Lab Francais Fractionnement & Biotechnol, F-91958 Courtaboeuf, France
来源：
REVUE DE MEDECINE INTERNE | 2004年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 5
页数：3
相关论文
共 50 条
  • [1] THE MECHANISMS OF ACTION OF IVIG IN AUTOIMMUNE AND INFLAMMATORY DISEASES: AN UPDATE
    Kaveri, V
    VOX SANGUINIS, 2013, 105 : 35 - 35
  • [2] Mechanisms of IVIG action in human autoimmune blistering diseases
    Liu, Z
    Li, N
    Zhao, M
    Hilario-Vargas, J
    Prisayanh, P
    Warren, S
    Roopenian, D
    Diaz, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (05) : 1088 - 1088
  • [3] INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
    DESOUZA, VR
    KAVERI, SV
    KAZATCHKINE, MD
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1993, 11 : S33 - S36
  • [4] INTRAVENOUS IMMUNOGLOBULINS (IVIG) IN THE TREATMENT OF AUTOIMMUNE-DISEASES
    KAVERI, SV
    DIETRICH, G
    HUREZ, V
    KAZATCHKINE, MD
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 86 (02): : 192 - 198
  • [5] New insights into IVIg mechanisms and alternatives in autoimmune and inflammatory diseases
    Norris, Peter A. A.
    Kaur, Gurleen
    Lazarus, Alan H.
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (06) : 392 - 398
  • [6] IVIG-mediated effector functions in autoimmune and inflammatory diseases
    Galeotti, Caroline
    Kaveri, Srini V.
    Bayry, Jagadeesh
    INTERNATIONAL IMMUNOLOGY, 2017, 29 (11) : 491 - 498
  • [7] Mechanisms of action of intravenous immunoglobulin (IVIg) in autoimmune and neuromuscular diseases
    Sharshar, T
    Kaveri, S
    Kazatchkine, M
    CLINICAL NEUROPHYSIOLOGY: FROM RECEPTORS TO PERCEPTION, 1999, 50 : 486 - 492
  • [8] IMMUNE MODULATING EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN AUTOIMMUNE-DISEASES
    MOUTHON, L
    KAVERI, S
    KAZATCHKINE, M
    TRANSFUSION SCIENCE, 1994, 15 (04): : 393 - 408
  • [9] Immunomodulatory effects of intravenous immunoglobulins (IVIg) in autoimmune diseases abstract.
    Mouthon, L
    Lacroix-Desmazes, S
    Pashov, A
    Kaveri, SV
    Kazatchkine, MD
    REVUE DE MEDECINE INTERNE, 1999, 20 : 423S - 430S
  • [10] PROPOSED MECHANISMS OF ACTION OF INTRAVENOUS IGG (IVIG) IN AUTOIMMUNE-DISEASES
    JUNGI, TW
    NYDEGGER, UE
    TRANSFUSION SCIENCE, 1992, 13 (03): : 267 - 290
12345